# Whole Body MRI for Cancer Surveillance in A-T

> **NCT05252819** · — · COMPLETED · sponsor: **University of Nottingham** · enrollment: 32 (actual)

## Conditions studied

- Ataxia Telangiectasia

## Interventions

- **DIAGNOSTIC_TEST:** Magnetic Resonance Imaging and an optional blood test

## Key facts

- **NCT ID:** NCT05252819
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-17
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05252819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05252819, "Whole Body MRI for Cancer Surveillance in A-T". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05252819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*